Search for Clinical Trial Results
Li-Fraumeni Syndrome - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion Condition: Malignant Pleural Effusion Date: 2015-04-24 Interventions:
|
Not yet recruiting |
Study Name: rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors Condition: Advanced Malignant Thyroid Tumors Date: 2009-05-12 Interventions:
|
Not yet recruiting |
Study Name: The p53 Colorectal Cancer Trial Condition:
|
Not yet recruiting |
Study Name: p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma Condition:
Date: 2015-09-11 Interventions:
|
Not yet recruiting |
Study Name: P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer Condition: Advanced Head and Neck Cancer Date: 2015-04-20 Interventions:
|
Recruiting |
Study Name: Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma Condition: Advanced Hepatocellular Carcinoma (HCC) Date: 2015-07-19 Interventions:
|
Recruiting |
Study Name: Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma Condition: Advanced Adult Hepatocellular Carcinoma Date: 2015-03-25 Interventions:
|
Recruiting |
Study Name: Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt Condition: Advanced Solid and Hematological TP53wt Tumors Date: 2014-05-19 Interventions:
|
Not yet recruiting |
Study Name: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Condition:
|
Recruiting |
Study Name: A Study Evaluating Venetoclax in Subjects With Chronic Lymphocytic Leukemia Whose Cancer Has Come Back or Who Had No Response to Previous Cancer Treatments Including Subjects Missing Part of Their Chromosome 17, or TP53 Gene Mutation; or Who Received Prior Treatment With a B-Cell Receptor Inhibitor Condition: Chronic Lymphocytic Leukemia (CLL) Date: 2016-11-30 Interventions: Drug: Venetoclax Tablet Other Name: ABT-199 |